Name | Number of supported studies | Average coverage | |
---|---|---|---|
luminal cell of prostate epithelium | 4 studies | 78% ± 5% |
Insufficient scRNA-seq data for expression of KLK2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 258162.20 | 244 / 245 | 100% | 3466.06 | 502 / 502 |
thymus | 100% | 666.56 | 651 / 653 | 18% | 0.60 | 111 / 605 |
spleen | 55% | 27.75 | 133 / 241 | 0% | 0 | 0 / 0 |
breast | 40% | 445.04 | 185 / 459 | 5% | 0.37 | 57 / 1118 |
uterus | 34% | 48.59 | 57 / 170 | 6% | 0.78 | 26 / 459 |
adrenal gland | 25% | 10.35 | 65 / 258 | 9% | 0.33 | 21 / 230 |
intestine | 30% | 22.59 | 285 / 966 | 1% | 0.04 | 7 / 527 |
pancreas | 19% | 13.28 | 62 / 328 | 11% | 0.50 | 20 / 178 |
skin | 18% | 12.74 | 331 / 1809 | 11% | 0.45 | 50 / 472 |
peripheral blood | 26% | 48.96 | 237 / 929 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 24% | 1.52 | 7 / 29 |
bladder | 19% | 29.67 | 4 / 21 | 5% | 1.15 | 25 / 504 |
liver | 15% | 8.84 | 34 / 226 | 7% | 0.25 | 28 / 406 |
kidney | 16% | 10.51 | 14 / 89 | 3% | 0.13 | 28 / 901 |
ovary | 16% | 13.09 | 29 / 180 | 1% | 0.02 | 3 / 430 |
stomach | 15% | 8.13 | 54 / 359 | 2% | 0.06 | 5 / 286 |
lung | 12% | 7.51 | 70 / 578 | 4% | 0.10 | 44 / 1155 |
esophagus | 14% | 11.90 | 198 / 1445 | 2% | 0.06 | 4 / 183 |
adipose | 11% | 21.21 | 135 / 1204 | 0% | 0 | 0 / 0 |
brain | 7% | 5.34 | 176 / 2642 | 4% | 0.13 | 28 / 705 |
heart | 10% | 9.55 | 85 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 10% | 64.58 | 130 / 1335 | 0% | 0 | 0 / 0 |
muscle | 8% | 7.11 | 64 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 5% | 0.15 | 4 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006508 | Biological process | proteolysis |
GO_0030141 | Cellular component | secretory granule |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005576 | Cellular component | extracellular region |
GO_0004252 | Molecular function | serine-type endopeptidase activity |
Gene name | KLK2 |
Protein name | Kallikrein 2, prostatic, isoform CRA_a (Kallikrein A3) Kallikrein-2 isoform 6 Kallikrein 2 isoform 6 preproprotein (Kallikrein related peptidase 2) Kallikrein-2 isoform 7 Kallikrein-2 isoform 8 Kallikrein-2 (EC 3.4.21.35) (Glandular kallikrein-1) (hGK-1) (Tissue kallikrein-2) Kallikrein-2 isoform 5 Kallikrein-2 isoform 4 Kallikrein related peptidase 2 Kallikrein 2 isoform 5 preproprotein |
Synonyms | KLK2A2 hCG_22932 hK2 KLNA3 hGK-1 |
Description | FUNCTION: Glandular kallikreins cleave Met-Lys and Arg-Ser bonds in kininogen to release Lys-bradykinin. |
Accessions | A0A2H4GDA5 A0A024R4J4 A0A2H4GDB1 Q6T775 M0R0M2 M0R1T3 ENST00000325321.8 [P20151-1] A0A2H4GDB0 P20151 ENST00000599568.1 M0QXQ7 M0R2W5 Q6T774 ENST00000597439.1 [P20151-3] ENST00000593493.5 ENST00000600690.5 ENST00000594174.5 ENST00000358049.8 [P20151-2] ENST00000391810.6 [P20151-4] M0R0M4 ENST00000597911.1 A0A075B7A6 ENST00000599121.5 ENST00000597727.5 ENST00000595050.1 A0A2H4GDA3 A0A2H4GDA4 ENST00000595316.5 |